As per Intent Market Research, the Intravenous Equipment Market was valued at USD 6.9 Billion in 2024-e and will surpass USD 11.4 Billion by 2030; growing at a CAGR of 8.6% during 2025 - 2030.
The intravenous (IV) equipment market plays a pivotal role in modern healthcare by providing essential tools for the administration of fluids, medications, and nutrients to patients. This market encompasses a wide range of products including IV catheters, infusion pumps, and sets, which are integral in hospitals, ambulatory surgical centers, and homecare settings. The growth of this market is driven by factors such as the increasing prevalence of chronic diseases, a rise in surgical procedures, and the growing demand for home healthcare solutions. Furthermore, advancements in IV technology have enhanced the efficiency, safety, and comfort of intravenous treatments, contributing to the continued expansion of the market.
As healthcare systems evolve to offer more personalized and cost-effective care, the use of intravenous equipment becomes more critical, particularly in settings where precision and patient safety are paramount. The demand for advanced IV devices is expected to grow significantly, driven by innovations in device functionality and the rising importance of patient-centered care.
IV Infusion Pumps Are Largest Owing to Their Role in Precision and Patient Safety
Among the various types of intravenous equipment, IV infusion pumps hold the largest market share due to their critical role in ensuring accurate fluid and medication administration. These devices are designed to deliver controlled amounts of fluids, nutrients, and medications over a specific period, making them indispensable in hospital settings, particularly for patients requiring intensive care or long-term treatments. IV infusion pumps are widely used in various medical applications, including oncology, anesthesia, and intensive care units (ICUs), where the precise delivery of drugs is crucial.
The growth of the IV infusion pump segment is also fueled by technological advancements that improve their functionality and safety. Modern infusion pumps come equipped with features such as wireless connectivity, dose error reduction systems (DERS), and patient monitoring capabilities, enhancing their utility in clinical environments. As hospitals and healthcare facilities continue to adopt automated, error-reducing technologies to improve patient outcomes, the demand for IV infusion pumps is expected to increase steadily.
Hospitals Are Largest End-Use Industry Owing to High Volume of Procedures Requiring IV Therapy
Hospitals remain the largest end-use industry for intravenous equipment due to the high volume of procedures that require IV therapy. With the rising number of patients undergoing surgeries, receiving chemotherapy, or requiring hydration and nutritional support, hospitals are the primary setting for IV equipment use. Additionally, hospitals are increasingly adopting advanced IV solutions such as infusion pumps and automated systems to streamline patient care, reduce human error, and enhance treatment accuracy.
As hospitals continue to be at the forefront of healthcare delivery, the demand for intravenous equipment will remain robust. The focus on improving patient safety, reducing complications related to medication administration, and increasing operational efficiency is driving hospitals to invest in state-of-the-art IV systems. Furthermore, with the growth of the global healthcare sector, hospitals are expected to maintain their dominance as the largest end-use industry for intravenous equipment.
Ambulatory Surgical Centers (ASCs) Are Fastest Growing End-Use Industry Owing to Increased Demand for Outpatient Procedures
Ambulatory Surgical Centers (ASCs) are the fastest-growing end-use industry in the intravenous equipment market, driven by the rising demand for outpatient procedures. ASCs provide a more cost-effective and convenient alternative to traditional hospital settings, and the growing preference for minimally invasive surgeries has led to an increased volume of surgeries performed in these centers. Intravenous equipment, particularly IV catheters and infusion pumps, plays a crucial role in ensuring the successful administration of fluids and medications during these procedures.
The expansion of ASCs is fueled by advancements in medical technology that allow for safer, quicker procedures with shorter recovery times. As a result, the need for efficient and reliable IV equipment in ASCs is growing rapidly. The shift toward outpatient care models and the desire for more affordable healthcare options are expected to continue driving the growth of ASCs, making them a key segment in the intravenous equipment market.
North America Is Largest Region Owing to High Healthcare Spending and Technological Advancements
North America is the largest region in the intravenous equipment market, driven by high healthcare spending, advanced medical infrastructure, and widespread adoption of technological innovations. The U.S. remains a key contributor to the region’s market share, with a large number of hospitals, healthcare facilities, and outpatient centers utilizing intravenous equipment for various medical procedures. The growing incidence of chronic conditions, such as diabetes and cancer, further boosts the demand for IV devices used in long-term care and infusion treatments.
Moreover, the increasing emphasis on patient safety and operational efficiency in healthcare settings is promoting the adoption of advanced IV infusion pumps, catheters, and sets in North America. The presence of leading medical device manufacturers and continuous research and development in the region further contribute to the growth of the intravenous equipment market. As North America continues to lead in healthcare innovation and patient care, it is expected to maintain its position as the largest region in the intravenous equipment market.
Competitive Landscape and Leading Companies
The intravenous equipment market is highly competitive, with several major players contributing to its growth. Leading companies in this market include Baxter International Inc., B. Braun Melsungen AG, Smiths Medical, Medtronic, and Terumo Corporation. These companies are known for their innovative products, including IV catheters, infusion pumps, and IV sets, which are widely used across hospitals, ASCs, and homecare settings.
To stay competitive, these companies are focusing on technological advancements, such as the development of smart infusion pumps with dose error reduction systems, and expanding their product portfolios to meet the growing demand for intravenous solutions. Additionally, strategic mergers, acquisitions, and partnerships are helping companies strengthen their position in the market. The increasing emphasis on patient safety, enhanced functionality, and cost-effectiveness is pushing manufacturers to innovate and offer high-quality IV solutions that improve clinical outcomes. As the demand for advanced IV equipment continues to rise globally, the competitive landscape will continue to evolve.
Recent Developments:
- Medtronic launched a new infusion pump system that allows for more precise drug delivery and reduces the risk of human error.
- Fresenius Kabi AG received FDA approval for a new range of IV infusion sets designed for enhanced safety and ease of use.
- B. Braun Melsungen AG expanded its intravenous catheters portfolio with a product designed for pediatric use.
- Teleflex Incorporated unveiled a next-generation IV cannula with an improved design to reduce patient discomfort.
- Terumo Corporation announced the launch of a new line of IV fluid administration systems for use in hospitals and outpatient clinics.
List of Leading Companies:
- B. Braun Melsungen AG
- Medtronic
- Smiths Medical
- Becton, Dickinson and Company
- Johnson & Johnson
- Fresenius Kabi AG
- Terumo Corporation
- Cook Medical
- Halyard Health
- Teleflex Incorporated
- Nipro Corporation
- ConvaTec
- AngioDynamics
- Rockwell Medical, Inc.
- Smith & Nephew
Report Scope:
Report Features |
Description |
Market Size (2024-e) |
USD 6.9 Billion |
Forecasted Value (2030) |
USD 11.4 Billion |
CAGR (2025 – 2030) |
8.6% |
Base Year for Estimation |
2024-e |
Historic Year |
2023 |
Forecast Period |
2025 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Intravenous Equipment Market by Type (IV Catheters, IV Sets, IV Infusion Pumps), by Application (Hospitals, Ambulatory Surgical Centers, Homecare), by End-Use Industry (Healthcare, Home Healthcare, Emergency Care), and by Region |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
B. Braun Melsungen AG, Medtronic, Smiths Medical, Becton, Dickinson and Company, Johnson & Johnson, Fresenius Kabi AG, Cook Medical, Halyard Health, Teleflex Incorporated, Nipro Corporation, ConvaTec, AngioDynamics, Smith & Nephew |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Intravenous Equipment Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030) |
4.1. IV Catheters |
4.2. IV Sets |
4.3. IV Infusion Pumps |
4.4. Others |
5. Intravenous Equipment Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
5.1. Hospitals |
5.2. Ambulatory Surgical Centers |
5.3. Homecare |
5.4. Others |
6. Intravenous Equipment Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
6.1. Healthcare |
6.2. Home Healthcare |
6.3. Emergency Care |
6.4. Others |
7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
7.1. Regional Overview |
7.2. North America |
7.2.1. Regional Trends & Growth Drivers |
7.2.2. Barriers & Challenges |
7.2.3. Opportunities |
7.2.4. Factor Impact Analysis |
7.2.5. Technology Trends |
7.2.6. North America Intravenous Equipment Market, by Type |
7.2.7. North America Intravenous Equipment Market, by Application |
7.2.8. North America Intravenous Equipment Market, by End-Use Industry |
7.2.9. By Country |
7.2.9.1. US |
7.2.9.1.1. US Intravenous Equipment Market, by Type |
7.2.9.1.2. US Intravenous Equipment Market, by Application |
7.2.9.1.3. US Intravenous Equipment Market, by End-Use Industry |
7.2.9.2. Canada |
7.2.9.3. Mexico |
*Similar segmentation will be provided for each region and country |
7.3. Europe |
7.4. Asia-Pacific |
7.5. Latin America |
7.6. Middle East & Africa |
8. Competitive Landscape |
8.1. Overview of the Key Players |
8.2. Competitive Ecosystem |
8.2.1. Level of Fragmentation |
8.2.2. Market Consolidation |
8.2.3. Product Innovation |
8.3. Company Share Analysis |
8.4. Company Benchmarking Matrix |
8.4.1. Strategic Overview |
8.4.2. Product Innovations |
8.5. Start-up Ecosystem |
8.6. Strategic Competitive Insights/ Customer Imperatives |
8.7. ESG Matrix/ Sustainability Matrix |
8.8. Manufacturing Network |
8.8.1. Locations |
8.8.2. Supply Chain and Logistics |
8.8.3. Product Flexibility/Customization |
8.8.4. Digital Transformation and Connectivity |
8.8.5. Environmental and Regulatory Compliance |
8.9. Technology Readiness Level Matrix |
8.10. Technology Maturity Curve |
8.11. Buying Criteria |
9. Company Profiles |
9.1. B. Braun Melsungen AG |
9.1.1. Company Overview |
9.1.2. Company Financials |
9.1.3. Product/Service Portfolio |
9.1.4. Recent Developments |
9.1.5. IMR Analysis |
*Similar information will be provided for other companies |
9.2. Medtronic |
9.3. Smiths Medical |
9.4. Becton, Dickinson and Company |
9.5. Johnson & Johnson |
9.6. Fresenius Kabi AG |
9.7. Terumo Corporation |
9.8. Cook Medical |
9.9. Halyard Health |
9.10. Teleflex Incorporated |
9.11. Nipro Corporation |
9.12. ConvaTec |
9.13. AngioDynamics |
9.14. Rockwell Medical, Inc. |
9.15. Smith & Nephew |
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Intravenous Equipment Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Intravenous Equipment Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Intravenous Equipment Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA